Literature DB >> 27296995

Evaluation of Adherence Should Become an Integral Part of Assessment of Patients With Apparently Treatment-Resistant Hypertension.

Elena Berra1, Michel Azizi1, Arnaud Capron1, Aud Høieggen1, Franco Rabbia1, Sverre E Kjeldsen1, Jan A Staessen1, Pierre Wallemacq1, Alexandre Persu2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27296995     DOI： 10.1161/HYPERTENSIONAHA.116.07464

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  32 in total

Review 1.  Hypertension: history and development of established and novel treatments.

Authors:  Milan Wolf; Sebastian Ewen; Felix Mahfoud; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2018-06-27       Impact factor: 5.460

Review 2.  Renal Artery Stenosis in Patients with Resistant Hypertension: Stent It or Not?

Authors:  Patricia Van der Niepen; Patrick Rossignol; Jean-Philippe Lengelé; Elena Berra; Pantelis Sarafidis; Alexandre Persu
Journal:  Curr Hypertens Rep       Date:  2017-01       Impact factor: 5.369

3.  Clarification of the Correct Nomenclature of the Amino Metabolite of Clonazolam: 8-Aminoclonazolam.

Authors:  Peter D Maskell; Claire Parks; Jenny Button; Huiling Liu; Denise A McKeown
Journal:  J Anal Toxicol       Date:  2021-02-13       Impact factor: 3.367

4.  [Therapy-resistant and therapy-refractory arterial hypertension].

Authors:  M Wallbach; M J Koziolek
Journal:  Internist (Berl)       Date:  2018-06       Impact factor: 0.743

Review 5.  Implications of Recent Clinical Trials and Hypertension Guidelines on Stroke and Future Cerebrovascular Research.

Authors:  Daniel T Lackland; Robert M Carey; Adriana B Conforto; Clive Rosendorff; Paul K Whelton; Philip B Gorelick
Journal:  Stroke       Date:  2018-02-21       Impact factor: 7.914

6.  Systolic Blood Pressure and Biochemical Assessment of Adherence: A Cross-Sectional Analysis in the Emergency Department.

Authors:  Candace D McNaughton; Nancy J Brown; Russell L Rothman; Dandan Liu; Edmond K Kabagambe; Phillip D Levy; Wesley H Self; Alan B Storrow; Sean P Collins; Christianne L Roumie
Journal:  Hypertension       Date:  2017-06-26       Impact factor: 10.190

7.  Therapeutic drug monitoring-guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence.

Authors:  Valeria Avataneo; Amedeo De Nicolò; Franco Rabbia; Elisa Perlo; Jacopo Burrello; Elena Berra; Marco Pappaccogli; Jessica Cusato; Antonio D'Avolio; Giovanni Di Perri; Franco Veglio
Journal:  Br J Clin Pharmacol       Date:  2018-08-15       Impact factor: 4.335

8.  Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.

Authors:  Robert M Carey; David A Calhoun; George L Bakris; Robert D Brook; Stacie L Daugherty; Cheryl R Dennison-Himmelfarb; Brent M Egan; John M Flack; Samuel S Gidding; Eric Judd; Daniel T Lackland; Cheryl L Laffer; Christopher Newton-Cheh; Steven M Smith; Sandra J Taler; Stephen C Textor; Tanya N Turan; William B White
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

Review 9.  Resistant Hypertension Updated Guidelines.

Authors:  Irene Chernova; Namrata Krishnan
Journal:  Curr Cardiol Rep       Date:  2019-08-30       Impact factor: 2.931

Review 10.  Italian Society of Arterial Hypertension (SIIA) Position Paper on the Role of Renal Denervation in the Management of the Difficult-to-Treat Hypertensive Patient.

Authors:  Rosa Maria Bruno; Stefano Taddei; Claudio Borghi; Furio Colivicchi; Giovambattista Desideri; Guido Grassi; Alberto Mazza; Maria Lorenza Muiesan; Gianfranco Parati; Roberto Pontremoli; Bruno Trimarco; Massimo Volpe; Claudio Ferri
Journal:  High Blood Press Cardiovasc Prev       Date:  2020-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.